OPPENHEIMER & CO INC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 762 filers reported holding NOVARTIS A G in Q3 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.

Quarter-by-quarter ownership
OPPENHEIMER & CO INC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$3,102,554
+1.1%
30,459
+0.1%
0.06%
+4.9%
Q2 2023$3,069,077
+7.4%
30,414
-2.1%
0.06%0.0%
Q1 2023$2,857,520
-0.2%
31,060
-1.6%
0.06%
-6.2%
Q4 2022$2,862,488
+13.6%
31,553
-4.8%
0.06%
+10.2%
Q3 2022$2,519,000
-14.1%
33,138
-4.4%
0.06%
-6.3%
Q2 2022$2,932,000
-7.4%
34,679
-3.9%
0.06%
+10.5%
Q1 2022$3,166,000
+30.1%
36,072
+29.6%
0.06%
+32.6%
Q4 2021$2,434,000
+8.4%
27,823
+1.4%
0.04%
+2.4%
Q3 2021$2,245,000
-23.8%
27,452
-15.0%
0.04%
-20.8%
Q2 2021$2,947,000
+2.6%
32,298
-3.8%
0.05%
-7.0%
Q1 2021$2,871,000
-21.8%
33,590
-13.6%
0.06%
-26.0%
Q4 2020$3,673,000
+7.8%
38,899
-0.7%
0.08%
-9.4%
Q3 2020$3,406,000
-2.9%
39,163
-2.4%
0.08%
-6.6%
Q2 2020$3,506,000
+2.9%
40,140
-2.9%
0.09%
-11.7%
Q1 2020$3,407,000
-14.1%
41,321
-1.4%
0.10%
+5.1%
Q4 2019$3,967,000
+1.4%
41,894
-6.9%
0.10%
-8.4%
Q3 2019$3,912,000
-4.0%
45,013
+0.9%
0.11%
-3.6%
Q2 2019$4,074,000
-5.6%
44,616
-0.6%
0.11%
-3.5%
Q1 2019$4,317,000
+33.6%
44,905
+19.2%
0.12%
+13.9%
Q4 2018$3,232,000
+2.3%
37,662
+2.7%
0.10%
+26.2%
Q3 2018$3,159,000
-17.6%
36,661
-27.8%
0.08%
-23.1%
Q2 2018$3,836,000
-4.1%
50,787
+2.6%
0.10%
+1.0%
Q1 2018$4,002,000
-2.4%
49,496
+1.3%
0.10%
-2.8%
Q4 2017$4,101,000
-2.0%
48,846
+0.2%
0.11%
-5.4%
Q3 2017$4,186,000
+9.2%
48,759
+6.1%
0.11%
+5.7%
Q2 2017$3,834,000
+40.9%
45,940
+25.4%
0.11%
+37.7%
Q1 2017$2,722,000
-0.7%
36,639
-2.7%
0.08%
-3.8%
Q4 2016$2,741,000
-8.0%
37,637
-0.2%
0.08%
-8.0%
Q3 2016$2,978,000
-6.8%
37,719
-2.6%
0.09%
-8.4%
Q2 2016$3,195,0000.0%38,725
-12.2%
0.10%
-2.1%
Q1 2016$3,195,000
-29.9%
44,114
-16.7%
0.10%
-28.7%
Q4 2015$4,559,000
-31.8%
52,978
-27.1%
0.14%
-33.0%
Q3 2015$6,680,000
-8.5%
72,673
-2.2%
0.20%0.0%
Q2 2015$7,304,000
+5.2%
74,276
+5.5%
0.20%
+7.4%
Q1 2015$6,941,000
+6.3%
70,392
-0.1%
0.19%
+1.1%
Q4 2014$6,528,000
+7.1%
70,454
+8.8%
0.19%
+3.3%
Q3 2014$6,094,000
+11.3%
64,736
+7.0%
0.18%
+9.7%
Q2 2014$5,476,000
+4.8%
60,480
-1.6%
0.16%
+5.1%
Q1 2014$5,224,000
+14.1%
61,441
+7.9%
0.16%
+7.5%
Q4 2013$4,578,000
+6.5%
56,953
+1.7%
0.15%
-3.3%
Q3 2013$4,297,000
+12.2%
56,010
+3.4%
0.15%
+2.0%
Q2 2013$3,830,00054,1640.15%
Other shareholders
NOVARTIS A G shareholders Q3 2013
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders